Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

FDA Orders Bayer To Extend Essure Post-Market Study

Dec 21 2018

• By Ferdous Al-Faruque

Bayer Pharma AG, Administration and laboratory buildings of Bayer HealthCare Pharmaceuticals in Berlin-Wedding on June 14, 2017, Germany - Image

Related Content

Patient Advocates Look To Leverage New Industry Scrutiny To Seek Publicity, Reforms

Nov 30 2018

Gottlieb Defends US FDA 2019 Budget, Device Safety Plan In House

Apr 18 2018

Essure Birth-Control Device Hit With New Restrictions From US FDA

Apr 10 2018

Public Interest Groups Will Leverage ‘Bleeding Edge’ Lessons To Push For Device Safety Changes

Sep 26 2018

Related Companies

Bayer AG

Additional Topics

Post Market Regulation & Studies FDA Safety Regulation Companies Implant Files Gynecology & Urology Medical Device

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window